Anzeige
Meldung des Tages: Lithium ist zurück — und diesmal führen Institutionen den Markt an

DBV Technologies Aktie News

Aktie
WKN:  A1JWB7 ISIN:  FR0010417345 US-Symbol:  DBVTF Branche:  Biotechnologie Land:  Frankreich
4,225 €
+0,375 €
+9,74%
23.01.26
Depot/Watchlist
Marktkapitalisierung *
436,97 Mio. €
Streubesitz
32,19%
KGV
-0,53
Index-Zuordnung
-

DBV Technologies News

29.07.25 - GlobeNewswire
DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq ...
28.07.25 - GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN ...
22.07.25 - GlobeNewswire
DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer
Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN ...
25.06.25 - GlobeNewswire
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old ...
12.06.25 - GlobeNewswire
DBV Technologies to Participate in Upcoming EAACI Congress 2025
Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock ...
11.06.25 - GlobeNewswire
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV ...
04.06.25 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025 (Article 223-16 of the General Regulations of the Autorité des ...
03.06.25 - GlobeNewswire
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN ...
15.05.25 - GlobeNewswire
Combined General Meeting of June 11, 2025
Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting ...
06.05.25 - GlobeNewswire
Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025
Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025 (Article 223-16 of the General Regulations of the Autorité des ...
05.05.25 - GlobeNewswire
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq ...
30.04.25 - GlobeNewswire
DBV Technologies Reports First Quarter 2025 Financial Results
Châtillon, France, April 30, 2025
11.04.25 - GlobeNewswire
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
Châtillon, France, April 11, 2025 DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ...
28.03.25 - GlobeNewswire
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
Châtillon, France, March 27, 2025 DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License ...
24.03.25 - GlobeNewswire
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application (BLA) for Viaskin® Peanut ...
25.02.25 - GlobeNewswire
DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
Châtillon, France, February 25, 2025 DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq ...

Newssuche

Videos

newspaper
22.01.26 -5,56%
Trading Insights vom 22.01.26
Preisschock bei Erdgas! Was sind die Gründe, wie geht man damit um? Gold auf neuem Allzeithoch: wie ... Mehr »